In a report released yesterday, Ryan Krueger from KBW assigned a Hold rating to Globe Life (GL – Research Report), with a price target of $130.00. The company’s shares closed yesterday at $66.39.
According to TipRanks, Krueger is a 5-star analyst with an average return of 13.1% and a 72.09% success rate. Krueger covers the Financial sector, focusing on stocks such as Globe Life, Ameriprise Financial, and Metlife.
In addition to KBW, Globe Life also received a Hold from Morgan Stanley’s Bob Huang in a report issued on April 12. However, on the same day, CFRA downgraded Globe Life (NYSE: GL) to a Sell.
Based on Globe Life’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.42 billion and a net profit of $274.8 million. In comparison, last year the company earned a revenue of $1.34 billion and had a net profit of $242.34 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Globe Life (GL) Company Description:
Globe Life, Inc. is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. The Life Insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurances. The Supplement Health Insurance segment provides generally guaranteed-renewable and include medicare supplement, critical illness, accident, and limited-benefit supplemental hospital, and surgical coverage. The Annuities segment refers to fixed-benefit contracts. The Investments segment covers the investment portfolio. The company was founded on November 19, 1979 and is headquartered in McKinney, TX.
